位置:首页 > 蛋白库 > EDN3_HUMAN
EDN3_HUMAN
ID   EDN3_HUMAN              Reviewed;         238 AA.
AC   P14138; E1P5I5; Q03229; Q7Z6D2; Q9UGT7;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   03-AUG-2022, entry version 213.
DE   RecName: Full=Endothelin-3;
DE            Short=ET-3;
DE   AltName: Full=Preproendothelin-3;
DE            Short=PPET3;
DE   Flags: Precursor;
GN   Name=EDN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2509452; DOI=10.1016/s0021-9258(19)84690-2;
RA   Bloch K.D., Eddy R.L., Shows T.B., Quertermous T.;
RT   "cDNA cloning and chromosomal assignment of the gene encoding endothelin
RT   3.";
RL   J. Biol. Chem. 264:18156-18161(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RC   TISSUE=Placenta;
RX   PubMed=2178974; DOI=10.1016/0014-5793(90)80583-5;
RA   Onda H., Ohkubo S., Ogi K., Kosaka T., Kimura C., Matsumoto H., Suzuki N.,
RA   Fujino M.;
RT   "One of the endothelin gene family, endothelin 3 gene, is expressed in the
RT   placenta.";
RL   FEBS Lett. 261:327-330(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-17.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG AND 3).
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PARTIAL PROTEIN SEQUENCE, CLEAVAGE BY KELL, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=10438732;
RA   Lee S., Lin M., Mele A., Cao Y., Farmar J., Russo D., Redman C.;
RT   "Proteolytic processing of big endothelin-3 by the kell blood group
RT   protein.";
RL   Blood 94:1440-1450(1999).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=9284755; DOI=10.1210/jcem.82.9.4209;
RA   Bourgeois C., Robert B., Rebourcet R., Mondon F., Mignot T.-M.,
RA   Duc-Goiran P., Ferre F.;
RT   "Endothelin-1 and ETA receptor expression in vascular smooth muscle cells
RT   from human placenta: a new ETA receptor messenger ribonucleic acid is
RT   generated by alternative splicing of exon 3.";
RL   J. Clin. Endocrinol. Metab. 82:3116-3123(1997).
RN   [10]
RP   STRUCTURE BY NMR OF ET-3.
RX   PubMed=1610811; DOI=10.1021/bi00139a030;
RA   Mills R.G., O'Donoghue S.I., Smith R., King G.F.;
RT   "Solution structure of endothelin-3 determined using NMR spectroscopy.";
RL   Biochemistry 31:5640-5645(1992).
RN   [11]
RP   REVIEW ON VARIANTS.
RX   PubMed=9359036;
RA   Hofstra R.M.W., Osinga J., Buys C.H.C.M.;
RT   "Mutations in Hirschsprung disease: when does a mutation contribute to the
RT   phenotype.";
RL   Eur. J. Hum. Genet. 5:180-185(1997).
RN   [12]
RP   VARIANT WS4B PHE-159.
RX   PubMed=8630503; DOI=10.1038/ng0496-445;
RA   Hofstra R.M.W., Tan-Sindhunata G., Wu Y., Kamsteeg E.-J., Stulp R.P.,
RA   van Ravenswaaij-Arts C., Majoor-Krakauer D., Angrist M., Chakravarti A.,
RA   Meijers C., Buys C.H.C.M.;
RT   "A homozygous mutation in the endothelin-3 gene associated with a combined
RT   Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg
RT   syndrome).";
RL   Nat. Genet. 12:445-447(1996).
RN   [13]
RP   VARIANT HSCR4 THR-224, AND VARIANT THR-17.
RX   PubMed=9359047;
RA   Bidaud C., Salomon R., Van Camp G., Pelet A., Attie T., Eng C.,
RA   Bonduelle M., Amiel J., Nihoul-Fekete C., Willems P.J., Munnich A.,
RA   Lyonnet S.;
RT   "Endothelin-3 gene mutations in isolated and syndromic Hirschsprung
RT   disease.";
RL   Eur. J. Hum. Genet. 5:247-251(1997).
RN   [14]
RP   INVOLVEMENT IN WS4B.
RX   PubMed=11303518; DOI=10.1136/jmg.38.3.205;
RA   Pingault V., Bondurand N., Lemort N., Sancandi M., Ceccherini I.,
RA   Hugot J.P., Jouk P.S., Goossens M.;
RT   "A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease:
RT   is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy
RT   phenotypes?";
RL   J. Med. Genet. 38:205-209(2001).
RN   [15]
RP   VARIANT WS4B CYS-127.
RX   PubMed=12189494; DOI=10.1007/s00439-002-0765-8;
RA   Pingault V., Girard M., Bondurand N., Dorkins H., Van Maldergem L.,
RA   Mowat D., Shimotake T., Verma I., Baumann C., Goossens M.;
RT   "SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex
RT   physiopathological mechanism.";
RL   Hum. Genet. 111:198-206(2002).
RN   [16]
RP   VARIANT THR-17.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E., Fennell T.,
RA   O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B., Tukiainen T.,
RA   Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K., Zhao F., Zou J.,
RA   Pierce-Hoffman E., Berghout J., Cooper D.N., Deflaux N., DePristo M.,
RA   Do R., Flannick J., Fromer M., Gauthier L., Goldstein J., Gupta N.,
RA   Howrigan D., Kiezun A., Kurki M.I., Moonshine A.L., Natarajan P.,
RA   Orozco L., Peloso G.M., Poplin R., Rivas M.A., Ruano-Rubio V., Rose S.A.,
RA   Ruderfer D.M., Shakir K., Stenson P.D., Stevens C., Thomas B.P., Tiao G.,
RA   Tusie-Luna M.T., Weisburd B., Won H.H., Yu D., Altshuler D.M.,
RA   Ardissino D., Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S., Laakso M.,
RA   McCarroll S., McCarthy M.I., McGovern D., McPherson R., Neale B.M.,
RA   Palotie A., Purcell S.M., Saleheen D., Scharf J.M., Sklar P.,
RA   Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C., Wilson J.G.,
RA   Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: Endothelins are endothelium-derived vasoconstrictor peptides.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Long;
CC         IsoId=P14138-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P14138-2; Sequence=VSP_001445;
CC       Name=3;
CC         IsoId=P14138-3; Sequence=VSP_043139;
CC   -!- TISSUE SPECIFICITY: Expressed in trophoblasts and placental stem villi
CC       vessels, but not in cultured placental smooth muscle cells.
CC       {ECO:0000269|PubMed:9284755}.
CC   -!- DISEASE: Hirschsprung disease 4 (HSCR4) [MIM:613712]: A disorder of
CC       neural crest development characterized by absence of enteric ganglia
CC       along a variable length of the intestine. It is the most common cause
CC       of congenital intestinal obstruction. Early symptoms range from
CC       complete acute neonatal obstruction, characterized by vomiting,
CC       abdominal distention and failure to pass stool, to chronic constipation
CC       in the older child. {ECO:0000269|PubMed:9359047}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- DISEASE: Waardenburg syndrome 4B (WS4B) [MIM:613265]: A disorder
CC       characterized by the association of Waardenburg features
CC       (depigmentation and deafness) with the absence of enteric ganglia in
CC       the distal part of the intestine (Hirschsprung disease).
CC       {ECO:0000269|PubMed:11303518, ECO:0000269|PubMed:12189494,
CC       ECO:0000269|PubMed:8630503}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the endothelin/sarafotoxin family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAR16083.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/edn3/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05081; AAA52405.1; -; mRNA.
DR   EMBL; X52001; CAA36252.1; -; mRNA.
DR   EMBL; BT007085; AAP35748.1; -; mRNA.
DR   EMBL; AY444503; AAR16083.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL035250; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75434.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75435.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75437.1; -; Genomic_DNA.
DR   EMBL; BC008876; AAH08876.1; -; mRNA.
DR   EMBL; BC053866; AAH53866.1; -; mRNA.
DR   CCDS; CCDS13477.1; -. [P14138-1]
DR   CCDS; CCDS13478.1; -. [P14138-2]
DR   CCDS; CCDS13479.1; -. [P14138-3]
DR   PIR; A34378; A34378.
DR   RefSeq; NP_001289384.1; NM_001302455.1.
DR   RefSeq; NP_001289385.1; NM_001302456.1.
DR   RefSeq; NP_996915.1; NM_207032.2. [P14138-3]
DR   RefSeq; NP_996916.1; NM_207033.2. [P14138-2]
DR   RefSeq; NP_996917.1; NM_207034.2. [P14138-1]
DR   PDB; 6IGK; X-ray; 2.00 A; B=97-117.
DR   PDBsum; 6IGK; -.
DR   AlphaFoldDB; P14138; -.
DR   BMRB; P14138; -.
DR   SMR; P14138; -.
DR   BioGRID; 108230; 132.
DR   STRING; 9606.ENSP00000337128; -.
DR   iPTMnet; P14138; -.
DR   PhosphoSitePlus; P14138; -.
DR   BioMuta; EDN3; -.
DR   DMDM; 119618; -.
DR   MassIVE; P14138; -.
DR   PaxDb; P14138; -.
DR   PeptideAtlas; P14138; -.
DR   PRIDE; P14138; -.
DR   ProteomicsDB; 53025; -. [P14138-1]
DR   ProteomicsDB; 53026; -. [P14138-2]
DR   ProteomicsDB; 53027; -. [P14138-3]
DR   Antibodypedia; 29284; 302 antibodies from 30 providers.
DR   DNASU; 1908; -.
DR   Ensembl; ENST00000311585.11; ENSP00000311854.7; ENSG00000124205.18. [P14138-3]
DR   Ensembl; ENST00000337938.7; ENSP00000337128.2; ENSG00000124205.18. [P14138-1]
DR   Ensembl; ENST00000371028.6; ENSP00000360067.2; ENSG00000124205.18. [P14138-1]
DR   Ensembl; ENST00000395654.3; ENSP00000379015.3; ENSG00000124205.18. [P14138-2]
DR   GeneID; 1908; -.
DR   KEGG; hsa:1908; -.
DR   MANE-Select; ENST00000337938.7; ENSP00000337128.2; NM_207034.3; NP_996917.1.
DR   UCSC; uc002yap.4; human. [P14138-1]
DR   CTD; 1908; -.
DR   DisGeNET; 1908; -.
DR   GeneCards; EDN3; -.
DR   HGNC; HGNC:3178; EDN3.
DR   HPA; ENSG00000124205; Tissue enhanced (brain, vagina).
DR   MalaCards; EDN3; -.
DR   MIM; 131242; gene.
DR   MIM; 613265; phenotype.
DR   MIM; 613712; phenotype.
DR   neXtProt; NX_P14138; -.
DR   OpenTargets; ENSG00000124205; -.
DR   Orphanet; 661; Congenital central hypoventilation syndrome.
DR   Orphanet; 388; Hirschsprung disease.
DR   Orphanet; 897; Waardenburg-Shah syndrome.
DR   PharmGKB; PA27616; -.
DR   VEuPathDB; HostDB:ENSG00000124205; -.
DR   eggNOG; ENOG502S4W0; Eukaryota.
DR   GeneTree; ENSGT00950000183053; -.
DR   InParanoid; P14138; -.
DR   OMA; QPSKWTL; -.
DR   OrthoDB; 1264335at2759; -.
DR   PhylomeDB; P14138; -.
DR   TreeFam; TF333184; -.
DR   PathwayCommons; P14138; -.
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   SignaLink; P14138; -.
DR   SIGNOR; P14138; -.
DR   BioGRID-ORCS; 1908; 8 hits in 1062 CRISPR screens.
DR   GeneWiki; Endothelin_3; -.
DR   GenomeRNAi; 1908; -.
DR   Pharos; P14138; Tbio.
DR   PRO; PR:P14138; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P14138; protein.
DR   Bgee; ENSG00000124205; Expressed in penis and 114 other tissues.
DR   ExpressionAtlas; P14138; baseline and differential.
DR   Genevisible; P14138; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0031708; F:endothelin B receptor binding; IPI:BHF-UCL.
DR   GO; GO:0005179; F:hormone activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0008283; P:cell population proliferation; IEA:Ensembl.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0010961; P:cellular magnesium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0048016; P:inositol phosphate-mediated signaling; IDA:BHF-UCL.
DR   GO; GO:0030318; P:melanocyte differentiation; IEA:Ensembl.
DR   GO; GO:0001755; P:neural crest cell migration; IEA:Ensembl.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IDA:BHF-UCL.
DR   GO; GO:0030072; P:peptide hormone secretion; IDA:BHF-UCL.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IGI:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:MGI.
DR   GO; GO:0010460; P:positive regulation of heart rate; IDA:BHF-UCL.
DR   GO; GO:0046887; P:positive regulation of hormone secretion; IDA:BHF-UCL.
DR   GO; GO:0002690; P:positive regulation of leukocyte chemotaxis; IDA:BHF-UCL.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; IDA:BHF-UCL.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0060585; P:positive regulation of prostaglandin-endoperoxide synthase activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IEA:Ensembl.
DR   GO; GO:0048070; P:regulation of developmental pigmentation; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IGI:MGI.
DR   GO; GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IDA:BHF-UCL.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0042310; P:vasoconstriction; IDA:BHF-UCL.
DR   GO; GO:0014826; P:vein smooth muscle contraction; IDA:BHF-UCL.
DR   InterPro; IPR020475; Endothelin.
DR   InterPro; IPR019764; Endothelin_toxin_CS.
DR   InterPro; IPR001928; Endothln-like_toxin.
DR   PANTHER; PTHR13874; PTHR13874; 1.
DR   Pfam; PF00322; Endothelin; 1.
DR   PRINTS; PR00365; ENDOTHELIN.
DR   SMART; SM00272; END; 2.
DR   PROSITE; PS00270; ENDOTHELIN; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cleavage on pair of basic residues;
KW   Deafness; Direct protein sequencing; Disease variant; Disulfide bond;
KW   Hirschsprung disease; Reference proteome; Secreted; Signal; Vasoactive;
KW   Vasoconstrictor; Waardenburg syndrome.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   PROPEP          17..94
FT                   /id="PRO_0000008111"
FT   PEPTIDE         97..117
FT                   /note="Endothelin-3"
FT                   /id="PRO_0000008112"
FT   PROPEP          118..238
FT                   /id="PRO_0000008113"
FT   REGION          24..89
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          159..173
FT                   /note="Endothelin-like"
FT   REGION          183..219
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        184..208
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            117..118
FT                   /note="Cleavage; by KEL"
FT   DISULFID        97..111
FT   DISULFID        99..107
FT   VAR_SEQ         181..196
FT                   /note="SNSRTAEKTDKEEEGK -> RQ (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:2178974"
FT                   /id="VSP_001445"
FT   VAR_SEQ         198..238
FT                   /note="EVKDQQSKQALDLHHPKLMPGSGLALAPSTCPRCLFQEGAP -> RGANRGL
FT                   CQRRLKSRTNKASRL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043139"
FT   VARIANT         17
FT                   /note="A -> T (in dbSNP:rs11570255)"
FT                   /evidence="ECO:0000269|PubMed:27535533,
FT                   ECO:0000269|PubMed:9359047, ECO:0000269|Ref.4"
FT                   /id="VAR_009078"
FT   VARIANT         127
FT                   /note="Y -> C (in WS4B; dbSNP:rs752400458)"
FT                   /evidence="ECO:0000269|PubMed:12189494"
FT                   /id="VAR_015238"
FT   VARIANT         159
FT                   /note="C -> F (in WS4B; dbSNP:rs74315384)"
FT                   /evidence="ECO:0000269|PubMed:8630503"
FT                   /id="VAR_002353"
FT   VARIANT         224
FT                   /note="A -> T (in HSCR4; risk factor associated with
FT                   disease susceptibility; dbSNP:rs11570351)"
FT                   /evidence="ECO:0000269|PubMed:9359047"
FT                   /id="VAR_009079"
FT   HELIX           105..113
FT                   /evidence="ECO:0007829|PDB:6IGK"
SQ   SEQUENCE   238 AA;  25454 MW;  7D7E90BC7DE37273 CRC64;
     MEPGLWLLFG LTVTSAAGFV PCSQSGDAGR RGVSQAPTAA RSEGDCEETV AGPGEETVAG
     PGEGTVAPTA LQGPSPGSPG QEQAAEGAPE HHRSRRCTCF TYKDKECVYY CHLDIIWINT
     PEQTVPYGLS NYRGSFRGKR SAGPLPGNLQ LSHRPHLRCA CVGRYDKACL HFCTQTLDVS
     SNSRTAEKTD KEEEGKVEVK DQQSKQALDL HHPKLMPGSG LALAPSTCPR CLFQEGAP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024